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Introduction
Neuralgic amyotrophy (NA) is a distinct clinical entity
[1]. Core features are the extreme neuropathic pain at
onset and the rapid development of multifocal pareses
and atrophy, usually in the upper extremity, as well as
the slow recovery in months to years. Sensory signs or
symptoms are usually not very marked, although on
careful examination patchy hypaesthesia can be found
in most patients. In the majority of patients, the right
shoulder is affected, and the tell-tale sign of NA for
most physicians is the conspicuous winging of the
shoulder blade, the scapula alata, although this is
present in only two-thirds of the patients. Especially in
the hereditary form, but sometimes also in extensive
attacks of idiopathic NA, other peripheral nerves
outside the brachial plexus can also be involved, such
as lower cranial nerves or the lumbosacral plexus.
Painless attacks occasionally, occur and are only rec-
ognized as NA because of a sudden patchy peripheral
paresis in the upper extremities without any identiﬁ-
able cause.
Neuralgic amyotrophy has both an idiopathic
(INA) and hereditary form (HNA). HNA (OMIM
162100) is autosomal dominant with a high but not
complete penetrance estimated at 80%. In the idio-
pathic form, patients usually suffer only one attack in
their life, but up to 25% may go on to suffer a
recurrence. In HNA attacks recur more frequently, in
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j Abstract Neuralgic amyotrophy
is a distinct clinical syndrome with
acute severe pain and patchy
paresis in the shoulder and arm
region. The clinical phenotype was
recently found to be more com-
prehensive and the long-term
prognosis less optimistic than
usually assumed for many pa-
tients. The disorder can be idio-
pathic or hereditary in an
autosomal dominant fashion, with
only few phenotypical variations
between the two. This article pro-
vides a practical overview of cur-
rent knowledge on the clinical
presentation, diagnosis, patho-
genesis and the treatment of pain
and complications.
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DOI 10.1007/s00415-006-0246-4almost 75% of the patients. [1] NA is more common
in men (male to female ratio 3 : 2), with an age of
onset in INA usually in the second or third decade but
ranging from the neonatal age to the seventh decade.
Patients with HNA tend to be younger when their ﬁrst
attack occurs, usually in their 2
nd decade. Although
neuralgic amyotrophy is considered a rare disease, the
minimum incidence of idiopathic NA is estimated at
2 - 4/10
5/year, making the disorder as common as the
Guillain-Barre ´ syndrome or primary malignant CNS
tumours [5, 15]. The hereditary form is much rarer,
with about 200 families known worldwide to date.
In the authors’ 10-year experience NA is still rel-
atively unknown to many physicians, even though the
clinical picture is usually typical. The initial diagnosis
is very often thought to be shoulder joint pathology or
cervical radiculopathy. Patients with NA are usually
ﬁrst seen by a family physician and referred to neu-
rologists and/or orthopedic surgeons, but may be
even more frequently referred to physical therapists at
ﬁrst or subsequently, especially in the initial phase
when the diagnosis has not yet been established. One
of the major problems in diagnosing neuralgic amy-
otrophy is that the course and localisation of both
pain and paresis can vary considerably among pa-
tients, and even among recurrent attacks in one pa-
tient. [1] Sometimes the only signs of an attack are
annoying pain in the upper arm lasting a few hours
with a subsequent loss of pinch grip for a few months,
caused by a lesion of the anterior interosseus nerve.
Conversely, the patient may have suffered from severe
pains in both shoulders and arms for weeks on end,
has a serious orthopnoea requiring nocturnal positive
pressure ventilation, and cannot use either of his or
her arms or hands in daily life for several years be-
cause of severe bilateral plexus damage with
involvement of both phrenic nerves.
This review aims to provide the neurological
practitioner with an update on the clinical features,
diagnosis and pathogenesis of neuralgic amyotrophy
and a practice-based overview of the current diag-
nostic and treatment options. Reported numbers and
percentages are derived from a recent cohort study
[1] unless noted otherwise.
Clinical presentation
j Pain types
An acute onset of an unusually severe and relentless
pain in the neck, shoulder and / or arm regions is very
characteristic of the disorder and occurs in 96% of all
patients. It often (61%) wakes patients in the middle
of the night or early morning, and usually increases to
maximum severity in a few hours. Then it has almost
invariably become very severe, and unlike anything
the patient experienced before (unless he or she had a
previous attack). Instructing the patient to grade the
pain on a scale of 0 to 10 (0 being no pain and 10 the
most severe pain imaginable) is an illustrative way of
making this clear, because initially 60% and subse-
quently 90% of the patients will have such a NRS
(Numerical Rating Scale) score of 7 or more, and the
median NRS is 8 at onset and 9 at maximum intensity.
The pain can also have a stuttering onset, and it can
take up to two weeks or more for paresis to develop.
Pain is usually worse at night and 94% of the patients
cannot sleep because of it. Typically attempts to
mitigate it by assuming certain postures or using
acetaminophen or NSAIDs provide no relief whatso-
ever, and patients often tell that the pain had them up
all night sitting on the couch with their arm pressed
tightly against their body, or even had them crawling
desperately on the ﬂoor not knowing what to do
anymore. It is a story not lightly forgotten once heard,
and the next patient will probably be recognized by it
too, making it a useful diagnostic tool.
Once the acute stage of an attack is over, i.e. the
initial pain has subsided and a patchy paresis and
atrophy have become evident, 77% of the patients will
go on to suffer from one or two additional types of
pain. First the damaged nerves in the plexus can give
rise to an increased mechanical sensitivity, eliciting
shooting or radiating neuropathic pain in the affected
nerves’ territory by putting strain on them through
extension, abduction or elevation of the arm (a ‘‘La-
segue sign of the arm’’). This hypersensitivity usually
dissipates after weeks to months. Additionally many
patients also develop musculoskeletal-type pain
localized to the origin or insertion of the paretic - or
compensating - muscles, especially in the periscapu-
lar, cervical and occipital regions. This pain may be
particularly therapy-resistant and can sometimes be-
come almost as incapacitating as the residual paresis
itself. The main risk for developing it seem to be
probably scapular instability caused by a paresis of
the serratus anterior, rhomboids or trapezius. One the
one hand this can lead to local myalgia and muscle
strain in the trapezius and levator scapulae if they
have to compensate for a downward and laterally
displaced scapula. Often it is maximally felt at the
points where these muscles attach to the occiput,
cervical spine or shoulder blade, and can radiate
further to the forehead - resembling tension-type
headache - or interscapular region. Myalgia and pain
at the attachment sites frequently also arises in paretic
periscapular muscles that (also) serve a postural
function. It is most often found in the serratus ante-
rior region, extending from the medial scapular edge
via the subscapular region and axilla to the midaxil-
lary chest wall where the muscle inserts onto the ribs.
696This pain can be so bothersome that it even prevents
normal breathing, because chest wall movement will
further increase it. Obviously this complication can be
even more impairing when the patient also has con-
comitant phrenic nerve dysfunction. Besides in the
serratus anterior region it may occur in the area of
any paretic muscle in NA. And ﬁnally, pain can result
from glenohumeral joint pathology such as rotator
cuff impingement or capsular irritation, developing as
a consequence of the altered shoulder biomechanics
in NA (see below).
j Motor and sensory symptoms
The second typical feature of NA, that can at the same
time make it difﬁcult to recognize by clinicians, is the
patchiness of the motor and sensory symptoms.
Histological studies have already shown that the
pathologic, presumably inﬂammatory, process can
cause very focal damage to one or a few of the fasci-
cles that make up a brachial plexus trunk or cord or a
peripheral nerve, while simultaneously scatteredly
affecting several parts of the plexus as a whole [2, 12].
This is reﬂected clinically by a wide variety in the
possible distribution - and severity - of paresis and
sensory deﬁcits. Any part of the brachial plexus, and
clinically any muscle or skin area can be involved, in
all sorts of combinations. Sensory symptoms or pain
tend not to correlate with the localisation of the
paresis. [1] It is precisely the recognition of this
patchiness that is a very important clue to the diag-
nosis of the plexopathy in NA.
There are several overall patterns of paresis that
occur more frequently than others. An upper brachial
plexus distribution - the periscapular and perihu-
meral muscles - is most common, and occurs in 71%
of the patients, either with (50%) or without (21%)
involvement of the long thoracic nerve that leads to
an unstable or winged scapula. Women have symp-
toms in a middle or lower brachial plexus distribution
twice as often (23%) as men (11%), including symp-
toms that mainly affect the interosseus anterior nerve,
with reduced pinch grip strength due to weakness of
the long thumb and index ﬁnger ﬂexors. Almost 80%
of the patients have sensory deﬁcits on examination,
and NA can also present with pain and sensory
symptoms only, frequently in the distribution of the
lateral cutaneous antebrachial nerve [18]. In 15%
of the attacks there are signs of distal autonomic
nervous system dysfunction (e.g. hand oedema,
vasomotor instability). Additionally, nerves outside
the distribution of the brachial plexus can also be
involved, and this occurs in 56% of the attacks in
HNA patients and in 17% of the attacks in the idio-
pathic form. They usually involve the lumbosacral
plexus (usually in a lumbar trunk distribution),
phrenic nerve or recurrent laryngeal nerve, but
occasionally more  exotic’ structures such as the facial
or abdominal nerves may be affected too.
One of the main pitfalls in the diagnostic phase is
that the patients tend to complain about that part of
their shoulder or arm that is most impaired by either
pain or paresis, but hardly notice or give attention to
other, lesser impairments in strength or sensory loss.
About a third of the attacks have bilateral involve-
ment that usually is asymmetrical in its severity, so
here too one side can easily get overlooked. As a
clinician one should be aware of this, and supplement
the history by a meticulous physical examination that
speciﬁcally pays attention to those muscles or skin
areas the patient doesn’t mention. Omitting this
increases the chance of either diagnostic errors (e.g.
making the clinical diagnosis of a mononeuropathy or
radiculopathy instead of a plexus lesion) or difﬁculty
in correctly explaining certain symptoms, such as
mistaking an unstable and downwardly displaced
scapula for atrophy of the trapezius muscle, or its
subsequent inability to move the arm overhead for a
deltoid paresis.
j Shoulder biomechanics
For most clinicians the biomechanics of shoulder and
arm movements are not part of daily practice. How-
ever, a little knowledge about the anatomical relations
between the scapula, chest wall and humerus will
greatly facilitate the understanding of why damage to
certain parts of the plexus or peripheral nerves gives
rise to impaired movements or joint complications
that cannot be explained by paresis only.
It is important to realize that the scapula, through
its glenoid cavity and acromial extension, forms half
of the glenohumeral joint, i.e. the socket. [20] For
ﬂuent movements of the arm it is necessary that the
other half, the humeral head, remains approximately
centered in its socket during the whole range of
motion. This is normally achieved through two
simultaneous mechanisms: rotation of the scapula to
optimize the position of the glenoid cavity, and the
action of several muscles that lift, depress or rotate
the humeral head during abduction to ensure its
optimal position (Figs. 1 and 2; reproduced with kind
permission of K. van Nugteren from ‘‘Orthopedische
Casuı ¨stiek’’). These two mechanisms must be able to
work in a well-coordinated fashion because otherwise
the humeral head will become impinged against the
acromion, initially compressing elements of the
interposed rotator cuff and subsequently making
further movement mechanically impossible due to
collision of both joint surfaces. The rotator cuff is
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teres minor and biceps tendons. At rest, the humeral
head is also kept in place by the action of the deltoid
muscle. Weakness < MRC 3 of this muscle can lead to
sagging of the humeral head, creating a dynamic
subluxation that depends on the residual strength and
fatigue of this muscle. Vice versa if the deltoid is
unaffected but the other cuff muscles are weak it can
also lead to a dynamic impingement because of
unopposed cranial elevation of the humeral head
during deltoid contraction (Fig. 2). The downward
and lateral displacement of the scapula on the chest
wall in case of serratus weakness also leads to an
altered position of the glenoid and acromion at
rest which makes the humeral head protrude - or
subluxate - anteriorly, increasing the chance of
impingement.
For ﬂuent abduction of the arm at a level of more
than 80 elevation scapular support of the humeral
head is indispensable. [16] The arm has to be tilted up
and outward by contraction of the supraspinatus and
deltoid, which can only be fully achieved when the
rotated humeral head is supported from below by the
scapular socket to be moved further up and out. This
means that when scapular movement is impaired, e.g.
when the serratus anterior is < MRC 3, abduction and
elevation will automatically be impaired above this
level, even when the deltoid supplying the force for
this movement is intact. When in doubt whether
insufﬁcient scapular movement or paresis of the del-
toid is responsible for decreased arm abduction, one
can attempt to ﬁxate the scapula by compressing it
against the chest while exerting counterpressure with
the other hand placed underneath the patients arm
anteriorly on the chest. In a case of pure serratus
weakness the patient should now be able to lift the
arm more easily to maximally 110 (to complete this
motion to 170 elevation scapular movement is re-
quired).
The periscapular - serratus anterior, trapezius,
rhomboid - muscles are not just important for
abduction and elevation of the arm. They also serve
an important postural function in stabilizing the
scapula to provide a ﬁxed support for any arm and
hand movements in front of or behind the trunk. In
this capacity they are activated in any body posture
except lying supine. This means that even sitting or
walking will cause symptoms when these muscles are
paretic, especially when the arms own weight cannot
be supported. When scapular instability and impaired
motion is present patients often subconsciously
attempt to compensate and increase stability by
adducting the shoulder through contraction of the
trapezius, in addition with lateroﬂexion of the trunk
to the contralateral side to elevate the affected
shoulder further and facilitate abduction by helping
tilt the humeral head anteriorly. Although in itself at
least partially effective, this strategy frequently leads
to myalgia in the trapezius and paraspinal muscles
due to strain.
j Physical examination and pitfalls
Because NA attacks frequently involve the proximal
or upper parts of the brachial plexus and therefore
often inﬂuences shoulder biomechanics, there are
some issues that merit special attention during the
physical examination. It is convenient to start out
with inspection of the shoulder blades, assessing
their respective position on the chest wall. In case of
Fig. 1 Transversal plane schematic of muscles keeping the humeral position
optimized against the scapula
Fig. 2 Coronal plane schematic of muscles that keeping the humeral position
optimized against the scapula
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weakness the shoulder blade sags a few centimeters
downward (because of the weight of the arm attached)
and in serratus palsy is usually also laterally displaced
with the lower border medially rotated at rest.
Winging, or a scapula alata, can be observed at rest
but becomes more prominent with arm movement. If
the affected shoulder appears to be higher than
the unaffected side it is usually because the patient
is compensating the downward scapular sagging
by tensing the trapezius muscle; after testing the
following relaxation will often show the downward
displacement at rest.
In case of severe serratus anterior weakness the
whole shoulder and arm can slide off the chest wall to
a more caudal and anterior position. If one is unaware
of this type of paresis, it can easily be mistaken for
atrophy of the trapezius muscle because the edge of
the shoulder is lower on that side. Sometimes we
found the aberrant position of the scapula in combi-
nation with supraspinatus atrophy had given rise to
the impression that a tumour protruded from the
shoulder blade, while in fact it was the crest of the
scapular spine.
Besides testing all the individual muscles or muscle
groups for strength grading, it is also useful to inspect
the so-called scapulothoracic and glenohumeral
rhythm in NA patients. The ﬁrst can be done by
having the patient slowly abduct and elevate the arm
in a coronal plane to the maximum of 170 degrees and
then moving it downward in the sagittal plane, and
vice versa. The normal scapular motion outwards
and inwards during this movement should be ﬂu-
ent, but when impaired it becomes jerky, indicat-
ing weakness of the serratus, or less often also the
rhomboids or trapezius. To test the glenohumeral
joint for impingement, the patients ﬂexed arm can
gently be lifted to maximum abduction in the coronal
plane by the examiner while keeping the other hand
on the acromion and humeral head; there should be
no crepitation, restriction of movement or local pain
in part of the arc and the humeral head should not
luxate (if necessary keep it ﬁxed with your ﬁngers to
prevent this). Restricted capsular movement can be
tested by passive arm exorotation, comparing the
range of excursions to that of the contralateral side.
During the previous tests it is also possible to note
any mechanical or stretch-sensitivity of the affected
nerves (a ‘‘Lasegue sign of the arm’’’).
As many patients experience musculoskeletal-type
pain in both affected and compensating muscles in
the months to years following an attack, which can
sometimes be difﬁcult to differentiate from the neu-
ropathic pains occurring in NA, it is useful to differ-
entiate these paintypes by palpating the bulk and
attachments of these muscles to detect atrophy,
hypertrophy and tenderness that points to strain. The
levator scapulae (a part of which can be palpated just
anterior to the trapezius at the point where the neck
changes into the shoulder), its insertion on the occi-
put and scapular crest, and the insertion of the pec-
toralis minor on the coracoid process are often
especially painful when the serratus anterior is weak.
Another pitfall we came across was the impression
of deltoid or biceps weakness in cases with scapular
instability. To avoid this inﬂuencing strength grad-
ing in these muscles, one may test the deltoid at about
70– 80 degrees lateral elevation, and have the patient
ﬁrmly adduct the ﬂexed elbow against the chest for
resistance testing the of biceps, thereby limiting the
role of scapular stability in these movements.
Because the phrenic nerve is involved in 7% (INA)
to 14% (HNA) of the patients it is also useful to
inspect the diaphragm for paradoxical breathing, i.e.
the in- and upward movement of the abdominal wall
during deep inspiration instead of the normal down-
and outward displacement. When present this is
strongly suggestive of (hemi-) diaphragmatic paraly-
sis, and this could be conﬁrmed by having the patient
bend over or lie down supine to see if there is
orthopnoea (which occurs due to even further
restriction of the lung volume by upward movement
of the abdominal contents in these positions).
As sensory deﬁcits in NA are often restricted to
relatively small skin areas, it is useful to compare
pinprick sensation of both sides in both shoulders,
arms and hands. Proprioceptic loss is very rare in NA,
but one can ﬁnd signs of vasomotor instability indi-
cating focal autonomic system dysfunction in the
forearm and hands of some 15% of the patients.
Diagnosis
Once heard of or seen before, neuralgic amyotrophy is
a very distinct clinical syndrome in 95% of the cases
[1], that can usually be recognized from the patients
history only. There are very few if any disorders in the
shoulder or arm region that are so extremely and
non-abatingly painful at onset, and once the patchy
paresis or atrophy sets in the diagnosis should be
readily apparent. A simple three-step way to diagnose
NA and differentiate it from its most common dif-
ferential diagnostic entities would be to start with the
following questions: is the pain acute, very severe
(NRS score >7) and unlike anything the patient had
before? If yes, NA is likely, if not NA is possible but
one should consider alternative diagnoses. Is there a
limitation of passive arm exorotation or abduction? If
not, NA is likely, but if yes shoulder joint pathology
(bursitis, tendinitis calcarea) is more likely. And
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disturbances) in the same root distribution? If not NA
is likely, if yes a cervical radiculopathy is more likely.
j Differential diagnosis of acute upper extremity
pain and paresis
However, some disorders mimic the clinical picture
of NA (Table 1). Cervical radiculopathies typically
present with posture-dependent radiating pain and
sensory disturbances, and sometimes paresis, in the
corresponding dermatome. As they are usually caused
by nerve root compression due to degenerative spinal
column disease, they occur most frequently at the
levels that suffer the largest amount of mechanical
strain during life. The estimated incidence of these
radiculopathies is highest at the C7 level (about 40/
10
5/year), and decreases towards more cranial levels
(C6: 14/10
5/year, C5: 5/10
5/year). [17] When they
present in an acute fashion it is likely that the cause is
a disk rupture with herniation, which usually occurs
at a single level at a time. If there is a progressive
degenerative spondylosis with foraminal stenosis pa-
tients can suffer from radiculopathies at multiple
levels simultaneously, but will present with gradually
progressive symptoms.
A true multiple mononeuritis, i.e. a peripheral
nervous system vasculitis, can give rise to multiple
progressive, but mostly distal focal nerve lesions in
the arms. As the chance of being affected by such a
vasculitic process is highest in the longest axons,
patients usually also suffer from focal neuropathies in
the legs and will often progress to a polyneuropathy-
like distribution of their symptoms. [8] Multiple focal
pareses in the arm can also be found in multifocal
motor neuropathy, a patchy, painless, and pure motor
inﬂammatory peripheral nervous system disorder
with a predilection for the forearm. Sometimes a
carpal tunnel syndrome can present atypically, with
pain and paraesthesias radiating up the arm to the
shoulder region. Rarely, a brachial plexopathy-like
distribution is seen in a focal subtype of motor neu-
ron disease called brachial amyotrophic diplegia. [11]
Of course non-neurological disorders, such as
inﬂammatory or degenerative shoulder, elbow, or
wrist joint disease also present with pain and limita-
tions of upper extremity movements.  Shoulder
complaints’ for example, are very common in the
general population, with an estimated incidence of
around 2000/10
5/year in the Netherlands. Careful
examination will usually reveal the arthrogenic cause,
and sensory symptoms or a real paresis are typically
not seen with these disorders. It can be difﬁcult to rule
out a paresis clinically though, for example in cases
with a biceps or supraspinatus tendon rupture
resulting in an inability to convey muscular contrac-
tion strength to the joint, or movements resulting in
increased pain that prevents any further attempts at
motion. Correctly identifying these symptoms as non-
neurological will require an adequate index of suspi-
cion and appropriate testing from the examiner.
j Differential diagnosis of plexopathies
When the clinical diagnosis of a brachial plexopathy
has been made, the aetiological possibilities are usu-
ally limited (Table 2). Many plexopathies are either
caused by direct trauma (e.g. a motor vehicle acci-
dent) or iatrogenic damage such as following irradi-
ation or surgery. The lower brachial plexus lesion
seen in patients with a Pancoast tumour has a distinct,
ominous course, with progressive pain and sensory
disturbances and eventually paresis, spreading from
the T2 and T1 segments to more proximal sites as the
tumour grows. A similar typical lower plexus distri-
bution pattern, of a more benign but still disabling
nature, can be seen in true neurogenic thoracic outlet
syndrome (incidence: 1 per million), in which the
lower trunk of the plexus containing the C8 and T1
root extensions becomes compressed by a ﬁbrous
band extending from an elongated C7 transverse
process to the ﬁrst rib. Typically the sensory distur-
bances are in the medial forearm and ulnar side of the
hand, while motor symptoms and atrophy prevail in
the thenar and to lesser extent in the hypothenar
muscles. [10]
When no cause is apparent and the plexopathy had
a rapid painful onset, the cause is most likely neu-
ralgic amyotrophy. Rarely, a similar picture but usu-
ally with progressive symptoms can be found with
direct peripheral nervous system infections such as
neuroborreliosis or HIV. In painless idiopathic bra-
chial plexopathies with only limited paresis and sen-
sory symptoms it can sometimes take weeks to
months before the patient notes anything is wrong. In
such a case it can be difﬁcult to exclude other insid-
ious causes such as a nerve or nerve sheath tumour of
the plexus. Even without additional investigations
clinical follow-up will then usually tell them apart, by
showing that the disorder is really progressive, as
would be expected in case of a neoplasm, or slowly
improving as it will in idiopathic cases. Rarely an-
other seemingly idiopathic and sometimes also pain-
ful brachial plexopathy can be the presenting
symptom in patients with a hereditary neuropathy
with liability to pressure palsies (HNPP), in which a
relatively minor stretch or compressive trauma can
damage the vulnerable nerves.[7] These patients
usually - but not always - have a (family) history of
compressive neuropathies at other sites (e.g. carpal
700tunnel syndrome or dropfoot), and signs of a poly-
neuropathy when they are older. HNPP can nowadays
be conﬁrmed both at the electrophysiological and
DNA level.
j Ancillary investigations in NA
Laboratory investigations can show some abnormal-
ities in about 25% of the patients (signs of previous
infection, mildly elevated CK, elevated liver enzymes
probably related to preceding infection, antiganglio-
side antibodies, slightly increased CSF protein con-
tent), but usually these ﬁndings do directly not
contribute to the diagnosis. In typical cases labora-
tory investigations are therefore unnecessary, but if
patients are in any way at risk it can be wise to rule
out a direct infectious cause for the plexopathy due to
neuroborreliosis or HIV because the initial clinical
picture can be identical.
Many clinicians will perform additional cervical
spine imaging by MRI or CT scan, in search for or to
rule out a cervical disk herniation or degenerative
changes. When the clinical lesion is that of a pure
monoradiculopathy with pain, sensory symptoms and
paresis all in the same dermatome it is certainly rec-
ommended as this combination of symptoms would
also be unusual in NA. But one should bear in mind
that a certain number of people have asymptomatic
disk herniation, especially at the C6–C7 level, and also
that the incidence of a cervical radiculopathy at the C5
level is equal to that of NA itself. [17] In more than
half of otherwise typical NA cases degenerative
changes of the cervical spine are found [1], and one
should therefore be cautious about placing too much
emphasis on the radiological rather than the clinical
picture. MRI scanning of the brachial plexus can be
warranted to rule out space-occupying lesions if the
symptoms are progressive. In NA it will typically
show no abnormalities, but in a small percentage T2
hyperintensity of affected plexus parts can be found.
Often chest radiography is performed to exclude
an apical lung (Pancoast) tumour, although the
chance of ﬁnding such a lesion is small when the
patient has an upper trunk brachial plexopathy of
acute onset. One advantage of this relatively simple
investigation is that it simultaneously evaluates the
position of the diaphragm halves, detecting a paresis
in some 10% of NA patients. If such a paresis is
already suspected on clinical grounds it is advisable to
include an ultrasound examination of diaphragm
movement or ﬂuoroscopy, and a pulmonary function
Table 2 Differential diagnosis of plexopathy aetiologies
Aetiology Difference with NA
Trauma direct relation in time with trauma, force direction predicts damage localisation
Postradiation usually 2–10 years after radiotherapy, slowly progressive, prominent paraesthesias
Post sterno- or thoracotomy lower trunk lesion, direct relation in time to surgery, resolves in weeks-months
True neurogenic thoracic outlet syndrome painless wasting of thenar > hypothenar, slowly progressive,
hypaesthesia in medial forearm
Peripheral nerve tumour gradual onset, usually slowly progressive, symptoms vary with localisation
Pancoast tumour insidious onset, progressive pain, symptoms spread from lower plexus to
middle and upper parts; Horner’s syndrome
Hereditary neuropathy with liability
to pressure palsies
often painless, can resolve rapidly, concomitant entrapment neuropathies,
polyneuropathy in elderly patients
Table 1 Differential diagnosis of upper extremity pain and/or paresis
Difference with NA
Neurological disorders
cervical radiculopathy, degenerative insidious onset, slowly progressive or fluctuating course
cervical radiculopathy, disk rupture acute onset, pain varies with posture, pain, sensory and motor
symptoms in same dermatome
mononeuritis multiplex / PNS vasculitis symptoms also in legs or distal arm, subacute onset, progressive
multifocal motor neuropathy painless, no sensory symptoms, distal predominance, progressive
brachial amyotrophic diplegia insidious onset, no sensory symptoms painless, progressive
Non-neurological disorders
shoulder or elbow joint pathology posture pain exacerbated by joint movement or usually relief at rest,
passive restriction of movement
cervical spondylosis with referred brachialgia often posture or activity dependent, no focal deficits, fluctuating course
complex regional pain syndrome vasomotor symptoms predominate diffuse pain and weakness subacute
onset with progression
701study comparing supine and sitting positions in the
diagnostic investigations (a difference of > 400–500
ml is abnormal and typical for diaphragmatic insuf-
ﬁciency).
An electrophysiological examination including
electromyography (EMG) and nerve conduction
studies (NCS) is generally the only ancillary investi-
gation that can positively support the diagnosis of
NA. [19] NCS can show reductions in the sensory
nerve action potential amplitudes in different brachial
plexus branches, excluding a solely radicular problem.
Motor nerve conduction studies are usually not very
informative unless the paresis is severe, in which case
the compound motor action potentials will be re-
duced in affected nerves. It can also be helpful in
evaluating the phrenic nerves. NCS can also help in
making other diagnoses unlikely, such as HNPP or
multifocal motor neuropathy in painless cases. Needle
examination will identify neurogenic abnormalities in
affected muscles, inform the examiner on the severity
of the lesions, and can conﬁrm that the involvement is
in a multifocal plexus distribution when clinical doubt
exists. Of course the same pitfall exists for the EMG as
for the clinical examination: one has to know which
affected muscles to study or otherwise the results will
be false negative and the diagnosis missed. In the ﬁrst
years after an attack EMG can show the extent of -
sometimes clinically unnoticeable - reinnervation and
recovery, making it an important tool in helping
predict functional outcome.
Pathogenesis
The exact pathophysiological mechanism of NA is as
yet unknown. The current hypothesis is that the at-
tacks are caused by an immune-mediated response to
one’s own peripheral nerves. [19] One of the main
indications that NA is an immune-mediated disorder
came from the fact that about half of the attacks are
preceded by an event that could have triggered the
immune system, such as infections, surgery, preg-
nancy and the puerperium,  stress’ (both mental and
strenuous physical exercise), immunisations, and
immunodulating therapies with interleukin-2 or in-
terferone-alfa2 [1, 6, 19]. However, two interesting
reports of NA epidemics showed that in addition to a
preceding infection mechanical factors or a speciﬁc
genetic background may also be a prerequisite to
trigger an attack. [3, 4] There are also patients who
had no obvious immunological preceding event but
described strenuous physical activity as a possible
trigger. And since there are many patients (46.8%)
who have not noticed any preceding event whatso-
ever, neither infection nor mechanical stress seem to
be able to explain the whole story of the onset of NA
attacks.
Additionally, immune-mediated mechanisms may
explain the occurrence of attacks, but do not yet tell us
why one person is susceptible to NA while another is
not. In patients with hereditary NA the genetic factor
seems the most logical choice for an explanation of at
least part of the underlying susceptibility. In the past
decades a number of HNA families were found to
harbour a genetic locus for the disorder on chromo-
some 17q25. In other families this could not be con-
ﬁrmed, implying that HNA is heterogeneous. [14]
RecentlythreemutationsintheSEPT9genewerefound
in several 17q25-linked families by effort of an exten-
sive international collaboration, although the role of
these mutations is still speculative [13]. The recent
ﬁnding that in INA patients the recurrence rate after a
ﬁrst episode is much higher (10–25%) than the inci-
dence of NA in the general population (2–3/10
6/year)
[1] strongly implies that these patients too must have
some sort of innate susceptibility to the attacks. In
summary, current evidence suggests that neuralgic
amyotrophy is a disorder with a complex pathophysi-
ologicalmechanisminwhichautoimmune,geneticand
external factors all seem to play an interwoven role.
Management
j Pain treatment
How and if pain should be treated depends mainly
on which stage of the attack the patient is in. As
described the pain in NA comes in different phases
and types: the acute neuropathic pain at onset,
residual neuropathic and mechanical hypersensitiv-
ity pain next, and ﬁnally musculoskeletal pains in
paretic and compensating muscles and sometimes the
shoulder joint that can remain as long as recovery is
incomplete. And although the initial pain is one of the
most characteristic features of the disorder the impact
of the subsequent pain types should not be underes-
timated, as about 1/3 of the patients still suffer from
these pains after an average follow-up of 6 years.
The acute phase pain has been found to respond
best to a combination of a long-acting NSAID and
opiate, such as diclofenac slow-release 100 mg bid
with slow-release morphine 10–30 mg bid [1]. The
sole use of an over-the-counter prescription such as
acetaminophen or a NSAID as a rule does not provide
adequate relief and should not be advised. Co-anal-
gesics such as gabapentin, carbamazepine or ami-
triptyline may be helpful for the second phase pain,
that is characterized by spontaneous or movement-
induced shooting pains and tingling sensations due to
702aberrant impulse ﬁring in the damaged, hypersensi-
tive parts of the plexus. These are not really suited for
use in the acute phase because of their delayed onset
of effect, which usually lasts about as long (several
weeks) as the acute phase pain itself.
j Physical therapy and rehabilitation
Treatment of the third, musculoskeletal type of pain
following an NA attack is much more of a challenge. In
practice it has been found very resistant to pharma-
cological and even sophisticated (e.g. nerve block)
pain treatment. The only effective intervention is
helping the patient re-establish an optimized biome-
chanical situation. This can be done by a combination
of physical therapy to maintain ﬂuent periscapular
motion and prevent dysfunctional compensating
strategies, and well-timed alternation between rest and
activities in daily life. Physical therapists can help with
pain recognition and prevention, and instruct the pa-
tient how to maintain ﬂuent scapulothoracic and
glenohumeralmotion. In addition,most therapistswill
attempt to optimize residual strength by certain
exercises, and the overall impression is that patients
who keep their affected limb active are better off
functionally. There are a few pitfalls, however, when it
comes to these strengthening exercises in NA. The
most common therapy failure occurs when attempts
are made to strengthen the intact compensating peri-
scapular muscles whilst the serratus anterior is weak.
Although the concept seems valid from a theoretical
point of view, there are almost no exercises of this type
that can be performed without concomitant serratus
activation. This makes patients very prone to devel-
oping (additional) myalgia and fatigue in this muscle
which will in turn keep them from further exercise.
A similar pitfall is seen when muscles with strength
below MRC grade 3 are trained using weights. Here
one can safely assume that if a muscle is not able to lift
the attached bodyweight against gravity it will cer-
tainly not be able to do so if extra kilos are added. And
ﬁnally one can say that in general trying to train
muscles that are already strained due to altered bio-
mechanics will inherently carry a risk of additional
strain and increasing symptoms of pain and fatigue.
The use of a foam rubber sling to support the
weight of the arm when sitting, standing or walking –
relieving the scapula-stabilizing muscles of the arm
weight – can be a useful part of this strategy, but one
should ensure that at the same time the patient
maintains full joint motion by passive or active
movement a few times a day to prevent contractures.
Quite often patients themselves are already applying
this support  trick’ by tucking their arm and hand in a
coat pocket when standing or walking. Commercially
available scapular braces can also provide support,
but have the disadvantage that they can only optimize
one of the two periscapular muscles functions (pos-
tural or kinetic) at a time. To ﬁxate the scapula
against the thorax for maximum stability they have to
be worn very tightly around the chest. This is both
uncomfortable and may even restrict normal breath-
ing excursion, and it prevents arm abduction above
110 elevation because of lack of scapular movement.
NA patients who found them supportive have usually
worn them less tightly, but just tight enough to pro-
vide a little support for the arm weight during sitting
and standing, similar to what a sling would do.
Treatmentofglenohumeraljointpathologyinvolves
physical therapy and local injection with a combined
anaesthetic and corticosteroid when capsular or ten-
don / cuff irritation or bursitis are present. In case of a
partial cuff tendon rupture rest is advised; a complete
rupturehasto besurgicallytreated.Itisalsoimportant
to look for work or daily life-associated movement
patterns that can maintain this type of complication
(especially repetitive arm movements or excessive
weight-bearing) and make the patient aware of this
association. In severe cases where conservative man-
agement fails, it may be necessary to resort to ortho-
paedic surgical intervention, but it goes without
saying that if possible one should aim to prevent this.
Patients with phrenic nerve palsy and orthopnoea
should be evaluated for nocturnal hypoventilation and
REM-sleep apnoeas, and treated with positive pressure
ventilation if required.
Since initially the severe pain will prevent many
patients from attending their work, the inevitable
questionwillarisewhenitiswisetoreturntowork.The
best answer to this question from the NA perspective
would be  at the earliest time possible’, because there is
no evidence that physical activities will prevent nerve
recovery or provoke another attack. However, it is
obvious that depending on the type of posture and the
activities required certain jobs will increase the chance
of complications described in the section on the third
pain phase. A gradual increase of activities, with
spreading of the amount of time spent in certain pos-
tures (e.g. sitting behind a desk, working with a key-
board, lifting objects) and alternating these physically
demanding activities with other less demanding tasks
will usually be preferable as long as weakness and
impairment is signiﬁcant. Fatigue was found to be a
complication of NA attacks in over a quarter of the
patients (unpublished observation) and seems to be
part of the NA phenotype in some. Spreading one’s
activities over the day and choosing what to spend
one’s energy on and what not seems the most reason-
able advice for these patients. For more speciﬁc help
and guidance we offer patients the consultation of a
specialized physiatrist as a part of standard care.
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